Stages of BMI, Glucose Control, and Endothelial Cell Activation in Malignancy with Diabetes Patients
DOI:
https://doi.org/10.3889/oamjms.2020.5130Keywords:
Diabetes, Malignancy, Glucose control, Body mass index, Endothelial cell activationAbstract
BACKGROUND: Abnormalities of glucose metabolism in diabetes can be an independent risk factor for the development and prognosis of cancer; it caused endothelial cell activation, inflammatory reactions. Hemostatic disorders, thrombosis, and various human organ damaged that will increase the morbidity and mortality rate. Diabetes was predicted to reach 552 million by 2030 in conjunction with rapid social and cultural changes. With the changes in lifestyle, body mass index (BMI) plays an important role in increasing the risk of metabolic diseases like diabetes type 2. One sign of endothelial cell activation is an increase in Von Willebrand Factor, which can be an early sign of increased coagulation activation until thrombosis occurs.
AIM: The aim of the study was to determine the correlation between BMI, glucose control, and endothelial cell activation in malignancy with diabetes patients.
METHODS: This is a case-control study with eighty samples. BMI, HbA1C, vWF, and D’dimer were measured.
RESULTS: There is a statistical significant correlation between blood glucose and HbA1C (p = 0.00), blood glucose and BMI (p = 0.037), HbA1C an BMI (p = 0.029), HbA1C and vWF (p = 0.03), HbA1C and age (p = 0.009), D’Dimer and vWF (p = 0.00), and age and BMI (p = −0.019), but no statistical significant between vWF and BMI (p = 0.97), vWF and age (p = 0.36).
CONCLUSIONS: There was an increased risk of thrombosis in malignancy with diabetes cases. BMI showed a significant correlation with blood glucose controlled, blood glucose control showed a significant correlation with the activation of the endothelial cell and hypercoagulable state.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Atkins RC, Zimmet P. Diabetic kidney disease: Act now or pay later. Saudi J Kidney Dus Transpl. 2012;21:217-21. PMid:20228503
Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: Pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23:3-13. https://doi.org/10.1002/dmrr.682 PMid:16960917
Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-40. https://doi. org/10.1001/jama.2009.726 PMid:19470990
Lam EK, Batty GD, Huxley RR, Martiniuk AL, Barzi F, Lam TH, et al. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific Region. Ann Oncol. 2011;22:730-8. https://doi.org/10.1093/annonc/mdq405 PMid:20705912
Shikata K, Ninomiya T, Kiyohara Y. Diabetes mellitus and cancer risk: Review of the epidemiological evidence. Cancer Sci. 2013;104:9-14. https://doi.org/10.1111/cas.12043 PMid:23066889
Richardson LC, Pollack LA. Therapy insight: Influence of Type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol. 2005;2:48-53. https://doi. org/10.1038/ncponc0062 PMid:16264856
International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7. https://doi. org/10.1038/414782a PMid:11742409
Hu FB. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249-57. https://doi. org/10.2337/dc11-0442 PMid:21617109
Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527-32. https://doi.org/10.1161/01.cir.0000091257.27563.32 PMid:14504252
Reininger AJ. VWF attributes-impact on thrombus formation. Thromb Res. 2008;122:S9-13. https://doi.org/10.1016/ s0049-3848(08)70028-8
Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care. 1999;22:C25-30. PMid:10189559
Hirano T, Ookubo K, Kashiwazaki K, Tajima H, Yoshino G, Adachi M. Vascular endothelial markers, Von Willebrand factor and thrombomodulin index, are specifically elevated in Type 2 diabetic patients with nephropathy: Comparison of primary renal disease. Clin Chim Acta. 2000;299:65-75. https://doi. org/10.1016/s0009-8981(00)00274-6
Blann AD, Lip GY. The endothelium in atherothrombotic disease: Assessment of function, mechanisms and clinical implications. Blood Coagul Fibrinolysis. 1998;9:297-306. https:// doi.org/10.1097/00001721-199806000-00001 PMid:9690800
Horowitz N, Brenner B. Thrombophilia and cancer. Pathophysiol Haemost Thromb. 2008;36:131-6. PMid:19176986
Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125:490-3. PMid:20097409
Sheth RA, Hesketh R, Kong DS, Wicky S, Oklu R. Barriers to drug delivery in interventional oncology. J Vasc Interv Radiol. 2013;24:1201-7. https://doi.org/10.1016/j.jvir.2013.03.034 PMid:23735316
Noble S, Pasi J. Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer. 2010;102:S2-9. https://doi. org/10.1038/sj.bjc.6605599 PMid:20386546
Nuttall FQ. Body mass index: Obesity, BMI, and health: A critical review. Nutr Today. 2015;50:117-28. PMid:27340299
Satwanti K, Mungreiphy NK, Rashmi S. Association between BMI, blood pressure, and age: Study among Tangkhul Naga tribal males of Northeast India. J Anthropol. 2011;2011:748147. https://doi.org/10.1155/2011/748147
Neelam A, Mukesh KA, Tannu K, Sunil K. Correlation between body mass index and blood glucose levels in Jharkhand population. Int J Contemp Res. 2017;4:1633-6.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Sry Suryani Widjaja (Author); Muhammad Syahputra; Almaycano Ginting (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
